Stories written by

Leena Menghaney

WHO’s essential diagnostics list could change the way patients think of access to treatment

So far, the availability of essential tests and diagnostics have widely been considered as facilities that patients and their families have to pay for.

Leena Menghaney
· Jun 27, 2018 · 02:30 pm
The new pharma FDI policy undermines Indian generics, which may make drugs more expensive

By relaxing brownfield pharma FDI norms, the government is making way for multinational corporations to take over 'Make in India' generics companies.

Leena Menghaney
· Jun 28, 2016 · 02:30 pm